GSK and Land Securities are in the FTSE 100 spotlight after the drugs giant sold its final Haleon shares and the property firm posted results.
The sale of GSK’s remaining 4% stake raised £1.25 billion, having held 13% following its 2022 demerger of the Panadol and Sensodyne business.
Land Securities revealed a smaller full-year loss of £341 million amid “robust” rental growth across its estate.
Haleon lower after GSK stake sale, Auto Trader down 5%
08:36 , Graeme Evans
The FTSE 100 index is 2.70 points lower at 8435.95, with traders on the sidelines ahead of eurozone inflation figures later this morning.
GSK fell 11p to 1772.5p and Haleon by 2p to 330.4p after the pharmaceuticals firm raised £1.25 billion selling the rest of its holding in the consumer healthcare business.
Land Securities shares were 9.5p lower at 680.5p following annual results, with FTSE 250-listed rival British Land down by 0.8p…
